Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
AstraZeneca Pharma India Limited ( (IN:ASTRAZEN) ) has issued an announcement.
AstraZeneca Pharma India Limited has announced that the record date for determining shareholders’ entitlement to the final dividend for the financial year 2024-25 is set for July 18, 2025. The final dividend, pending shareholder approval, is scheduled to be paid or dispatched by September 12, 2025, reflecting the company’s commitment to returning value to its shareholders.
More about AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited operates in the pharmaceutical industry, focusing on the development and distribution of medicines and healthcare products. The company is part of the global AstraZeneca group, which is known for its innovative treatments in various therapeutic areas.
Average Trading Volume: 3,717
Current Market Cap: 232.4B INR
For a thorough assessment of ASTRAZEN stock, go to TipRanks’ Stock Analysis page.